We advise strict due diligence to all platform users before committing to a transaction!

Amphetamine Dependence: Causes, Symptoms, and Diagnosis

Amphetamine Addiction

The U.S. Food and Drug Administration approved certain amphetamines to manage and treat ADHD, obesity and narcolepsy, specifically dextroamphetamine and levoamphetamine. Physical addiction appears to occur when repeated use of a drug changes the way your brain feels pleasure. The addicting drug causes physical changes to some nerve cells (neurons) in your brain. Opioids are narcotic, painkilling drugs produced from opium or made synthetically. This class of drugs includes, among others, heroin, morphine, codeine, methadone, fentanyl and oxycodone. Use of hallucinogens can produce different signs and symptoms, depending on the drug.

Related MedlinePlus Health Topics

  • Optimal psychosocial interventions accompanying medication must also be considered.
  • More evidence is needed, particularly from high-quality population-level studies and longitudinal cohort studies, in order to accurately quantify this risk.
  • Misusing or taking amphetamines that your provider did not prescribe to you can cause dangerous side effects and could lead to addiction or death.

In the Srisurapanont 1999b study, participants had to meet the additional criteria of having an Amphetamine Withdrawal Questionnaire (AWQ) score of 10 or higher. The combined mean duration of amphetamine use histories and length of time since last use of amphetamine prior to admission for the two studies on amineptine was 23.6 months and 55.2 hours, respectively. Participants in the Kongsakon 2005 study were detainees from a probation facility who were diagnosed with amphetamine dependence by DSM‐IV criteria. All the participants in this study were males and had an average age of 24.3 years.

Types of amphetamines

Amphetamine Addiction

The sensitivity analyses were done by the inclusion and exclusion of the data obtained from these studies. If both analyses point to the same conclusion in the respect of significant heterogeneity of data, the meta‐analyses including the data obtained from these studies were taken into consideration. Otherwise, the meta‐analyses conducted by the exclusion of the data obtained from these studies were considered. In this course, participants explore the multifaceted management of amphetamine toxicity.

  • One rationale guiding selection of medications for amphetamine withdrawal involves using a medication to stabilize dopamine, norepinephrine or serotonin neurotransmission to provide relief from withdrawal symptoms.
  • A substance addiction is a chronic condition that causes you to seek out and use substances despite harmful consequences.
  • Citations were uploaded to an online systematic review tool (© 2019 Covidence, ; Veritas Health Innovation Ltd.).
  • It’s even possible to develop a use disorder if you take amphetamines according to your doctor’s directions.

References to other published versions of this review

Amphetamine Addiction

The most common secondary outcome measure reported was craving (25 times), predominantly reported using the visual analogue scale (VAS) (16 times, 64% of the cravings measures). Risk of bias in individual study methods and reporting are included in Supplementary Table 1 and Supplementary Data (see ESM) as considerations across a number of domains. Across all studies, allocation of participants was by random assignment, and all but three studies [46, 56, 66] were double-blind. Study completion rates were low, with studies reporting the proportion of the sample who did not complete the protocol as 38.4% of the total randomised. Eighty-three percent of studies analysed their results by intention-to-treat, while five (12%) [33, 46, 53, 57, 61] were unclear in this regard and two (5%) [24, 45] did not. Females were underrepresented in the data, being only 29.7% of the total participants.

  • D. Incomplete outcome data were considered for all outcomes except for discontinuation rates.
  • They received their optimal dose of MES-amphetamine XR, an equivalent dose of lisdexamfetamine in terms of d-amphetamine base, or placebo.
  • This medication and others are currently in clinical trials, while new compounds are being developed and studied in preclinical models.
  • Instead, we pooled adjusted effects that were reported in the included studies.

As a molecule with a single chiral centre, amphetamine exists in two optically active forms, i.e. the dextro- (or d-) and levo- (or l-) isomers or enantiomers (Figure 1). Smith, Kline and French synthesised both isomers, and in 1937 commenced marketing of d-amphetamine, which was the more potent of the two isomers, under the trade name of Dexedrine®. Sales of Benzedrine and Dexedrine in chemist stores were unrestricted until 1939, when these drugs could only be obtained either on prescription from a registered medical practitioner or by signing the Poison Register (Bett, 1946). In his 1946 review, Bett commented on the widespread amphetamine addiction use of ‘energy pills’ by the allied forces in World War II, estimating that 150 million Benzedrine tablets were supplied to British and American service personnel during the course of the global conflict. In spite of considerable coverage in the medical literature and the popular press describing the powerful central effects of these new drugs, the addictive potential of amphetamine was largely dismissed (see Bett, 1946; Guttmann and Sargent, 1937; Tidy, 1938). Amphetamines contain a methyl group to the alpha position on its carbon chain resulting in lipophilicity, increasing its volume of distribution, and CNS stimulation.

  • Amineptine was voluntarily withdrawn from the market in 1999 due to reports of amineptine abuse.
  • Variation in the measurement of mental health outcomes made it difficult to interpret pooled effects (particularly for violence).
  • There was no difference in MA use by UDS in the treatment arm compared with placebo in the extended-release studies [29, 56].
  • These medications are part of the phenethylamine group, which includes drugs that can cause hallucinations, enhance a desire for social contact, or act as stimulants.

Treatment algorithm

Optimal psychosocial interventions accompanying medication must also be considered. Further and substantial investment to determine effective pharmacotherapies is required. Given bupropion’s licensed indication as a smoking cessation aid, unsurprisingly in one study examining the effects of bupropion on both smoking and stimulant use, participants randomised to bupropion were more likely to reduce their smoking compared with placebo [66]. Amphetamines and other stimulant drugs are second only to cannabis as the most widely used class of (illicit) drugs globally, accounting for 68 million past-year consumers [1]. Approximately 29 million people worldwide aged 15–65 years were estimated to have consumed amphetamines in the past year to 2017 [1]. Another way to produce a more gentle increase of brain dopamine is to bind d-amphetamine to a support.

Types of Illegal Amphetamines

This damage leads to dysregulation of glutamate in the cerebral cortex, a precursor to psychosis. Prior psychiatric studies have found that GABAergic cortical dysfunction seems to relate to schizophrenia. Amphetamines include the drug amphetamine and its many variants such as methamphetamine (speed or crystal meth) and methylenedioxymethamphetamine https://ecosoberhouse.com/ (MDMA, Ecstasy, or Adam). Amphetamines are usually taken by mouth but can be snorted, smoked, or injected. Amphetamines are stimulant drugs that are used to treat certain medical conditions but are also subject to abuse. At this time, there is no medicine that can help reduce the use of amphetamines by blocking their effects.

Amphetamine Addiction

Amphetamine Addiction

Misusing amphetamines, or taking them in a different way than a doctor prescribes, can lead to amphetamine addiction. Other common side effects of amphetamine include insomnia, headache, dry mouth, tachycardia, increase in systolic blood pressure, restlessness, and irritability. Lisdexamfetamine may be preferred if there is increased concern for misuse by the patient or a household member, as its chemically-phased release allows for once-daily dosing and may theoretically deter abuse. Lisdexamfetamine is available as capsules or chewable tablets, and typical daily dosages range from 20 mg to 70 mg.

Your mental health is affected

Compare listings

Compare